Question 1

What is the Meaning of PARP1?

Accepted Answer

PARP1, or Poly(ADP-ribose) polymerase 1, is a nuclear enzyme primarily responsible for detecting and signaling DNA damage. It acts as a critical first responder to single-strand breaks in the DNA helix, initiating a repair cascade vital for maintaining genomic stability and cellular health.

Question 2

What is the Context of PARP1?

Accepted Answer

Within the cell nucleus, PARP1 operates as a surveillance protein, constantly monitoring genetic code integrity. Its rapid activation upon DNA lesion detection underscores its pivotal role in the cell's immediate response to genotoxic stress, preventing mutation accumulation.

Question 3

What is the Significance of PARP1?

Accepted Answer

Clinically, PARP1 holds considerable importance, particularly in oncology, where its inhibition has transformed treatment strategies for specific cancer types. Targeting PARP1 in tumors with pre-existing DNA repair deficiencies, such as BRCA1/2 mutations, exploits a synthetic lethality pathway, leading to selective cancer cell death. This therapeutic approach offers precision medicine.

Question 4

What is the Mechanism of PARP1?

Accepted Answer

Upon encountering DNA strand breaks, PARP1 binds to the damaged site and catalyzes ADP-ribose unit transfer from NAD+ molecules onto various nuclear proteins, including itself. This process, poly(ADP-ribosylation), creates a scaffold recruiting other DNA repair proteins to the lesion, facilitating efficient repair.

Question 5

What is the Application of PARP1?

Accepted Answer

The clinical application of PARP1 modulation is primarily seen in PARP inhibitors as anticancer agents. These small molecule drugs block PARP1's activity, rendering cancer cells with compromised homologous recombination repair pathways unable to mend their DNA damage, leading to their demise. Such inhibitors are approved for ovarian, breast, prostate, and pancreatic cancers.

Question 6

What is the Metric of PARP1?

Accepted Answer

The efficacy of PARP1-targeted therapies is monitored through various clinical metrics, including objective response rates by imaging, progression-free survival, and overall survival. Specific biomarkers, such as BRCA1/2 mutations and homologous recombination deficiency scores, are crucial for patient selection and predicting therapeutic response.

Question 7

What is the Risk of PARP1?

Accepted Answer

While PARP inhibitors offer significant therapeutic benefits, their use is associated with potential risks and side effects requiring careful clinical management. Common adverse events include hematologic toxicities like anemia, neutropenia, and thrombocytopenia, plus gastrointestinal disturbances. A rare but serious risk involves myelodysplastic syndrome or acute myeloid leukemia development.

PARP1

Meaning

Context

Significance

Mechanism

Application

Metric

Risk

How Do NAD+ Precursors Influence Cellular Repair Mechanisms Relevant to Growth Hormone Action?